Kazazian Asset Management, LLC Bridge Bio Pharma, Inc. Transaction History
Kazazian Asset Management, LLC
- $123 Billion
- Q1 2025
A detailed history of Kazazian Asset Management, LLC transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Kazazian Asset Management, LLC holds 11,840 shares of BBIO stock, worth $494,083. This represents 0.33% of its overall portfolio holdings.
Number of Shares
11,840
Previous 13,520
12.43%
Holding current value
$494,083
Previous $371 Million
10.33%
% of portfolio
0.33%
Previous 0.28%
Shares
2 transactions
Others Institutions Holding BBIO
# of Institutions
362Shares Held
185MCall Options Held
12.8MPut Options Held
2.09M-
Viking Global Investors LP22.1MShares$920 Million2.55% of portfolio
-
Kohlberg Kravis Roberts & Co. L.P. New York, NY19.3MShares$804 Million30.7% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.9MShares$622 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$519 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X07.17MShares$299 Million0.14% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $6.19B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...